CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway

Youssef Aissouni1, Grzegorz Zapart, Juan L Iovanna

  • 1INSERM, U.624, 13288 Marseille, France.

Insights

The CIN85 protein interacts with MEKK4, enhancing the p38 MAP kinase pathway activation during cellular stress. This interaction is crucial for regulating cellular stress responses through MAPK pathways.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Signal Transduction

Background:

  • CIN85 (Cbl-interacting protein of 85 kDa) is a multi-adaptor protein regulating receptor tyrosine kinases and neuronal cell survival.
  • It possesses three SH3 domains that bind proline-arginine motifs (PxxxPR) in effector proteins.

Purpose of the Study:

  • To identify and characterize novel CIN85-interacting partners.
  • To elucidate the role of CIN85 in the regulation of MAPK pathways, particularly in response to cellular stress.

Main Methods:

  • Co-immunoprecipitation assays to confirm protein-protein interactions.
  • In vitro binding assays to map interaction domains.
  • Western blotting to assess protein activation and ubiquitination.
  • Stimulation assays using oxidative stress and growth factors.

Main Results:

  • MEKK4 (MAP kinase kinase kinase 4) was identified as a novel binding partner of CIN85.
  • The interaction is mediated by CIN85 SH3 domains binding to three PxxxPR motifs in MEKK4.
  • CIN85 binding to MEKK4 enhances MKK6 and p38 MAP kinase activation following oxidative stress and growth factor stimulation.
  • CIN85 regulates MEKK4 activation by GADD45 proteins and promotes MEKK4 multi-ubiquitination.

Conclusions:

  • CIN85 plays a novel role in regulating cellular stress responses.
  • CIN85 modulates MAPK pathway signaling through its interaction with MEKK4.
  • This interaction is critical for the cellular response to oxidative stress and growth factor signaling.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...